FR2840809B1 - Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme - Google Patents

Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme

Info

Publication number
FR2840809B1
FR2840809B1 FR0307276A FR0307276A FR2840809B1 FR 2840809 B1 FR2840809 B1 FR 2840809B1 FR 0307276 A FR0307276 A FR 0307276A FR 0307276 A FR0307276 A FR 0307276A FR 2840809 B1 FR2840809 B1 FR 2840809B1
Authority
FR
France
Prior art keywords
derma
prevention
treatment
hippophae rhamnoides
hydrophilic fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0307276A
Other languages
English (en)
Other versions
FR2840809A1 (fr
Inventor
Stephane Laclau
Celine Laperdrix
Jean Renaud Robin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories de Biologie Vegetale Yves Rocher SA
Original Assignee
Laboratories de Biologie Vegetale Yves Rocher SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories de Biologie Vegetale Yves Rocher SA filed Critical Laboratories de Biologie Vegetale Yves Rocher SA
Priority to FR0307276A priority Critical patent/FR2840809B1/fr
Publication of FR2840809A1 publication Critical patent/FR2840809A1/fr
Application granted granted Critical
Publication of FR2840809B1 publication Critical patent/FR2840809B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
FR0307276A 2002-06-17 2003-06-17 Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme Expired - Fee Related FR2840809B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0307276A FR2840809B1 (fr) 2002-06-17 2003-06-17 Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207438A FR2840808A1 (fr) 2002-06-17 2002-06-17 Composition cosmetique, dermatologique ou pharmaceutique contenant une fraction hydrophile de fruit de hippophae rhamnoides et son utilisation
FR0307276A FR2840809B1 (fr) 2002-06-17 2003-06-17 Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme

Publications (2)

Publication Number Publication Date
FR2840809A1 FR2840809A1 (fr) 2003-12-19
FR2840809B1 true FR2840809B1 (fr) 2008-09-26

Family

ID=29595305

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0207438A Pending FR2840808A1 (fr) 2002-06-17 2002-06-17 Composition cosmetique, dermatologique ou pharmaceutique contenant une fraction hydrophile de fruit de hippophae rhamnoides et son utilisation
FR0307276A Expired - Fee Related FR2840809B1 (fr) 2002-06-17 2003-06-17 Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0207438A Pending FR2840808A1 (fr) 2002-06-17 2002-06-17 Composition cosmetique, dermatologique ou pharmaceutique contenant une fraction hydrophile de fruit de hippophae rhamnoides et son utilisation

Country Status (1)

Country Link
FR (2) FR2840808A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1837054B1 (fr) * 2006-03-22 2011-06-29 The Procter & Gamble Company Compositions cosmétiques comprenant de l'argousier
DE102007010861B4 (de) * 2007-03-01 2008-11-20 Coty Prestige Lancaster Group Gmbh Kosmetisches Lichtschutzmittel
FR2943255B1 (fr) * 2009-03-17 2012-02-24 Rocher Yves Biolog Vegetale Utilisation cosmetique d'un extrait d'hippophae
FR2968552B1 (fr) * 2010-12-14 2012-12-28 Rocher Yves Biolog Vegetale Utilisation cosmetique d'un extrait de manne de frene
FR2971940B1 (fr) 2011-02-28 2015-04-03 Am Phyto Conseil Extrait de rameaux d'hippophae et son utilisation dans une composition cosmetique
FR3097127B1 (fr) 2017-10-03 2022-09-16 Basf Beauty Care Solutions France Sas Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique
FR3071742B1 (fr) 2017-10-03 2020-07-10 Basf Beauty Care Solutions France Sas Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique
CN111407695B (zh) * 2020-03-27 2022-09-30 陕西海天制药有限公司 一种沙棘水及其制备方法和应用
CN113940909B (zh) * 2021-11-12 2023-03-14 广州睿森生物科技有限公司 一种调节昼夜节律的组合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU852331A1 (ru) * 1979-08-20 1981-08-07 Харьковская Парфюмерно-Косметическаяфабрика Крем дл лица
RU2033790C1 (ru) * 1991-12-06 1995-04-30 Фейго Геноховна Репова Средство для ухода за кожей лица "фай"
US5578307A (en) * 1992-01-17 1996-11-26 Alfatec-Pharma Gmbh Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use
RU2048802C1 (ru) * 1992-08-25 1995-11-27 Инновационный центр "Ареал Д" Крем для кожи
CN1056966C (zh) * 1993-12-23 2000-10-04 李建中 沙棘麦饭石营养液
RU2089177C1 (ru) * 1994-02-03 1997-09-10 Государственный научный центр вирусологии и биотехнологии "Вектор" Средство для ухода за кожей
DE4431394C1 (de) * 1994-08-25 1996-02-15 Heilscher Karl Prof Dr Sc Verfahren zur Kaltgewinnung von Klarsaft, Trub und Öl aus Sanddornbeeren und ihre Verwendung
RU2085185C1 (ru) * 1994-10-14 1997-07-27 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Косметическое средство для ухода за кожей
RO112158B1 (ro) * 1995-09-29 1997-06-30 Bogdan Cristian Calinescu Medicamente pentru tratarea afecțiunilor dermatologice
DE19544905A1 (de) * 1995-12-01 1997-06-05 Robugen Gmbh Verfahren zur Herstellung von Pflanzenextrakten
RU2110984C1 (ru) * 1996-01-03 1998-05-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Косметический марикрем для ухода за кожей
US6221918B1 (en) * 1999-09-05 2001-04-24 Siberian Center For Natural Technologies, Inc. Combination of carotenoids for use as dietary supplement or topical ointment
DE10110545A1 (de) * 2001-03-05 2002-09-12 Anja Soedergreen Heilanwendungen aus der Sandornfrucht
FR2829695B1 (fr) * 2001-09-14 2004-03-19 Sederma Sa Utilisation de la seve de bouleau dans des compositions cosmetiques et dermopharmaceutiques

Also Published As

Publication number Publication date
FR2840809A1 (fr) 2003-12-19
FR2840808A1 (fr) 2003-12-19

Similar Documents

Publication Publication Date Title
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
IL173129A0 (en) 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
FR2867778B1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
CA2392879A1 (fr) Derive de pyrrolidine acetamide seul ou combine pour traiter des affections du snc
NO20001001D0 (no) Poly (ADP-ribose) polymerase ("PARP") inhibitorer, fremgangsmõte og farmasøytiske sammensetninger for behandling av neurale og kardiovaskulære vevskader
FR2795800B1 (fr) Appareil de prevention d'inversion d'ecoulement
EP1767197A3 (fr) Trategies therapeutiques pour la prevention et le traitement de la maladie d'alzheimer
MA29084B1 (fr) Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2840809B1 (fr) Utilisation d'une fraction hydrophile de fruit de hippophae rhamnoides pour la prevention et le traitement du derme
DK1458399T3 (da) Pregnansteroider til brug i behandlingen af CNS-sygdomme
CA2451519A1 (fr) Comprime contenant de la cetirizine et de la pseudoephedrine
PT1360187E (pt) 3,7-diazabiciclo(3.3.0)octanos e a sua utilizacao no tratamento de arritmias cardiacas
GB0113182D0 (en) Mild antimicrbial liquid cleansing formulations
ITBO960329A0 (it) Apparecchiatura sanitaria per l'assistenza a persone inferme, in particolare per l'ausilio nell'espletamento di funzioni fisiologiche.
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
FR2826269B1 (fr) Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee
CA2353808A1 (fr) Agent permettant d'abaisser les niveaux d'endotheline
FR2861300B1 (fr) Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

CL Concession to grant licences

Name of requester: YVES ROCHER FRANCE, FR

Effective date: 20160111

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20180228